Kawanishi, Japan

Takefumi Gemba


 


Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 129(Granted Patents)


Location History:

  • Kawanishi, JP (2009 - 2016)
  • Kawanishi-Hyogo, JP (2017)
  • Kagoshima, JP (2017 - 2019)

Company Filing History:


Years Active: 2009-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Takefumi Gemba: Innovator in Antibacterial and Angiogenesis-Inducing Polypeptides

Introduction

Takefumi Gemba, an esteemed inventor based in Kawanishi, Japan, has made significant strides in the field of biotechnology with his innovative research. With a total of five patents to his name, Gemba has focused his efforts on developing novel polypeptides that possess both antibacterial and angiogenesis-inducing properties. His work addresses critical medical challenges, particularly in the treatment of wounds and infections.

Latest Patents

Among Gemba's latest patents are groundbreaking inventions that utilize unique polypeptides known for their exceptional antibacterial activities and capabilities to induce angiogenesis. One notable patent describes a polypeptide that can be used in wound-healing drugs. This drug contains an effective ingredient that aids in the prevention and treatment of various conditions, including burns, decubitus, skin ulcers, and diabetic ulcers. The polypeptide has a defined amino acid sequence as specified in SEQ ID NOs:1 to 6, 8, and 10.

Another important patent reveals the broader medical applications of Gemba's polypeptides. These compounds not only enhance wound healing but also combat bacterial infections associated with various skin wounds. Their therapeutic potential is significant in addressing intractable wounds and conditions related to arteriosclerosis obliterans.

Career Highlights

Gemba's career includes pivotal roles at prestigious companies, such as Anges Mg, Inc. and Funpep Inc. His contributions to these organizations have paved the way for advancements in medical biotechnology, showcasing his dedication to enhancing human health through innovative solutions.

Collaborations

Gemba has collaborated with notable colleagues in the industry, including Hideki Tomioka and Nao Tamura. These partnerships have facilitated the exchange of ideas and expertise, contributing to the successful development of his patented innovations.

Conclusion

Takefumi Gemba stands out as a prominent inventor in the field of biotechnology. His groundbreaking work in developing polypeptides with antibacterial and angiogenesis-inducing activities has significant implications for medical treatment and wound care. As he continues to innovate, Gemba inspires future generations of inventors and researchers in the pursuit of advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…